Unraveling the Impact of Six Pentacyclic Triterpenes Regulating Metabolic Pathways on Lung Carcinoma Cells

Anamaris Torres-Sanchez,Grace Torres,Sthephanie Estrada,Daraishka Perez,Carlos Garcia,Melissa Milian,Eddian Velazquez,Valerie Molina,Yamixa Delgado
DOI: https://doi.org/10.3390/ph17060694
IF: 4.6
2024-05-28
Pharmaceuticals
Abstract:Recently, there has been great interest in plant-derived compounds known as phytochemicals. The pentacyclic oleanane-, ursane-, and lupane-type triterpenes are phytochemicals that exert significant activity against diseases like cancer. Lung cancer is the leading cause of cancer-related death worldwide. Although chemotherapy is the treatment of choice for lung cancer, its effectiveness is hampered by the dose-limiting toxic effects and chemoresistance. Herein, we investigated six pentacyclic triterpenes, oleanolic acid, ursolic acid, asiatic acid, betulinic acid, betulin, and lupeol, on NSCLC A549 cells. These triterpenes have several structural variations that can influence the activation/inactivation of key cellular pathways. From our results, we determined that most of these triterpenes induced apoptosis, S-phase and G2/M-phase cycle arrest, the downregulation of ribonucleotide reductase (RR), reactive oxygen species, and caspase 3 activation. For chemoresistance markers, we found that most triterpenes downregulated the expression of MAPK/PI3K, STAT3, and PDL1. In contrast, UrA and AsA also induced DNA damage and autophagy. Then, we theoretically determined other possible molecular targets of these triterpenes using the online database ChEMBL. The results showed that even slight structural changes in these triterpenes can influence the cellular response. This study opens up promising perspectives for further research on the pharmaceutical role of phytochemical triterpenoids.
pharmacology & pharmacy,chemistry, medicinal
What problem does this paper attempt to address?
### Problems Addressed by the Paper This paper aims to investigate the effects of six pentacyclic triterpenoids (oleanolic acid, ursolic acid, asiatic acid, betulinic acid, betulin, and lupeol) on non-small cell lung cancer (NSCLC) A549 cells. Specifically, the researchers hope to address the following issues through this study: 1. **Cell Cycle Arrest**: Investigate whether these pentacyclic triterpenoids can induce cell cycle arrest at the S phase and G2/M phase, and compare this with the commonly used chemotherapy drug cisplatin. 2. **DNA Damage**: Assess whether these compounds can cause DNA damage, particularly by activating DNA damage mechanisms. 3. **Apoptosis and Autophagy**: Determine whether these compounds can induce apoptosis and autophagy by detecting the externalization of phosphatidylserine and caspase 3 activity. 4. **Oxidative Stress**: Study whether these compounds can increase the production of total intracellular ROS (reactive oxygen species) and mitochondrial ROS. 5. **Chemoresistance Markers**: Evaluate whether these compounds can downregulate the expression of chemoresistance markers such as MAPK/PI3K, STAT3, and PD-L1. ### Research Background - **Current Status of Lung Cancer**: Lung cancer is the leading cause of cancer-related deaths worldwide, with NSCLC accounting for approximately 85% of all lung cancer cases. Although chemotherapy is the preferred method for treating lung cancer, its efficacy is limited by toxicity and chemoresistance. - **Plant-Derived Compounds**: In recent years, plant-derived compounds (such as pentacyclic triterpenoids) have attracted significant attention due to their notable anticancer activity. These compounds have different structural variations that may affect the activation or inactivation of key cellular pathways. ### Key Findings - **Cytotoxicity**: Cell viability was measured using the MTS/PMS colorimetric method, and it was found that these pentacyclic triterpenoids exhibited cytotoxicity at different concentrations. Among them, ursolic acid (UrA) was most cytotoxic to normal lung fibroblasts MRC5, while betulinic acid (BeA) was most cytotoxic to A549 cells. - **Cell Cycle Arrest**: All pentacyclic triterpenoids induced cell cycle arrest at the S phase and G2/M phase in A549 cells, with a higher degree of arrest compared to cisplatin. - **DNA Damage**: Only ursolic acid (UrA) and asiatic acid (AsA) significantly activated DNA damage mechanisms. - **Apoptosis and Autophagy**: Almost all pentacyclic triterpenoids induced early apoptosis and caspase 3 activity, with ursolic acid (UrA) and betulin (Betu) showing the most significant effects. - **Oxidative Stress**: These compounds significantly increased the production of total intracellular ROS and mitochondrial ROS. - **Chemoresistance Markers**: Most pentacyclic triterpenoids downregulated the expression of MAPK/PI3K, STAT3, and PD-L1, with betulinic acid (BeA) being the most effective in inhibiting these genes. ### Conclusion This study reveals the potential mechanisms of action of these six pentacyclic triterpenoids in lung cancer cells, providing new perspectives for further research on these compounds as anticancer drugs.